从LEAD队列中成年喘患者的分子IgE敏感性分析:精确医学方法
Huey-Jy Huang1,2, Robab Breyer-Kohansal3,4, Katarzyna Niespodziana1
1Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Allergy
|August 30, 2025
概括
在73.2%的喘患者中,分子过敏诊断确定了IgE敏感性,从而实现了个性化治疗. 对IgE敏感的患者年轻,肺功能更好,指导精准医学治疗喘的方法.
科学领域:
- 过敏和免疫学
- 呼吸系统医学
- 精准医学
背景情况:
- 喘是一种慢性呼吸道疾病,具有多种类型和内型.
- 准确的诊断对于区分过敏和非过敏喘至关重要.
- 这对于开发有针对性的精准医学治疗来说至关重要.
研究的目的:
- 在成年喘患者中分析IgE对多种过敏原分子的敏感性.
- 为了比较IgE敏感和非IgE敏感的喘患者.
- 探索过敏原特定免疫疗法的概念.
主要方法:
- 分析了来自奥地利LEAD队列的436名成年喘患者.
- 使用微阵列过敏原 (110个分子) 和皮肤刺伤测试 (SPT).
- 在IgE敏感和非IgE敏感组之间比较临床喘参数.
主要成果:
- 73. 2% 的喘患者表现出对呼吸道过敏原的IgE敏感性.
- 贝特v1,Ole e1,Feld1和家尘是最常见的过敏原.
- 对IgE敏感的患者年龄较小,肺功能较好,胆固醇细胞数量较低.
结论:
- 分子过敏诊断有效地识别了喘中的IgE敏感性.
- 这使得像免疫疗法这样的个性化治疗能够分层治疗患者.
- 促进精准医学方法,包括对喘的生物治疗.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Allergic Reactions
28.5K
Overview
28.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451
Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576


